Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis - Wikidata - awgldk - TriplyDB

Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis

Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis

http://www.wikidata.org/entity/Q34408930

about

Sphingolipids in High Fat Diet and Obesity-Related Diseases LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential Sphingolipids in spinal cord injury Alterations of the Ceramide Metabolism in the Peri-Infarct Cortex Are Independent of the Sphingomyelinase Pathway and Not Influenced by the Acid Sphingomyelinase Inhibitor Fluoxetine Ceramide-Initiated Protein Phosphatase 2A Activation Contributes to Arterial Dysfunction In Vivo.Novel Applications of Radionuclide Imaging in Peripheral Vascular Disease.The role of molecular imaging in the evaluation of myocardial and peripheral angiogenesis.Endothelial HO-1 induction by model TG-rich lipoproteins is regulated through a NOX4-Nrf2 pathway Synergistic effects of metformin with liraglutide against endothelial dysfunction through GLP-1 receptor and PKA signalling pathway Modulation of VEGF receptor 2 signaling by protein phosphatases.Insights into the molecular mechanisms of diabetes-induced endothelial dysfunction: focus on oxidative stress and endothelial progenitor cells.Endothelial Dysfunction in Obesity.Sphingolipids and their metabolism in physiology and disease.Novel Interconnections in Lipid Metabolism Revealed by Overexpression of Sphingomyelin Synthase-1.Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism.Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium.Palmitic Acid Reduces Circulating Bone Formation Markers in Obese Animals and Impairs Osteoblast Activity via C16-Ceramide Accumulation.Akt/eNOS signaling pathway mediates inhibition of endothelial progenitor cells by palmitate-induced ceramide.

P2860

Q26773230-CC3A679E-789C-41B4-BF2E-3A1F5BFC7246 Q26865711-0705CB8A-9A8A-4F7A-AEA0-5389DD0CCEC5 Q27026103-221FB5E6-C196-4B72-87DA-1A75E0A4E8E7 Q28270227-FC00BFBD-E7FA-4D44-A0A2-974FAE5FE389 Q36186252-AE844BCB-B231-43A3-A7E2-4F6CFB792E12 Q36307762-F9C9DCF2-D03D-49F9-B5F7-83455D089FF6 Q36322895-B7A032EB-2A73-4756-A0EC-40E3D0E25749 Q37033129-382C9EC1-3077-4039-A637-377F6CE805D8 Q37618348-352D6B87-A406-4E04-A8F8-9C7114B25841 Q39020269-233C760D-D535-4FF0-8296-6D7CCAC8B49E Q42145401-7257CF76-505B-4570-AE62-9D99FCEB761E Q46355665-09A6FB36-E161-4A95-BF2E-8F65539FDFA3 Q47374235-6F7A3418-84CB-43E9-BB42-424431651D71 Q48579084-87F63D7B-96EC-48D8-98E0-65D69F0755EA Q50896241-5D557602-8BC6-43A4-9DE8-C945CE7FA3C6 Q52368982-F0AA6C3C-37CE-46FD-ABB1-BDDF2A9AFF58 Q52889452-1C2A9601-EF99-409A-B8AD-872CF3F7257E Q54310846-6D2BA7C7-177B-4D51-8B50-1FF00C0CBEF0

P2860

Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis

http://www.wikidata.org/entity/Q34408930

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Ceramide-activated phosphatase ...... ance and impaired angiogenesis

@ast

Ceramide-activated phosphatase ...... ance and impaired angiogenesis

@en

Ceramide-activated phosphatase ...... ance and impaired angiogenesis

@nl

type

label

Ceramide-activated phosphatase ...... ance and impaired angiogenesis

@ast

Ceramide-activated phosphatase ...... ance and impaired angiogenesis

@en

Ceramide-activated phosphatase ...... ance and impaired angiogenesis

@nl

prefLabel

Ceramide-activated phosphatase ...... ance and impaired angiogenesis

@ast

Ceramide-activated phosphatase ...... ance and impaired angiogenesis

@en

Ceramide-activated phosphatase ...... ance and impaired angiogenesis

@nl

P1433

Q34408930-0C642923-4B0C-402D-99E3-93EF48C43519

P1476

Q34408930-6F77B035-A2C8-47D5-92A2-895668AF47C5

P2093

Q34408930-296E21CB-371D-4E1E-BADB-6399380490D6

Q34408930-527063A7-76E4-4E04-B487-B674BCF5D396

Q34408930-54C53322-A019-482C-94AF-4F2330AD14B7

Q34408930-57CBD8E4-D3D9-4C21-8049-FC2BA4CEB7D6

Q34408930-7ABBF783-B785-4027-8712-423A36682D16

Q34408930-AC2D89B7-B25A-4487-BFE7-0702C0F37F3F

Q34408930-AE864C8B-5F77-460F-A417-E50E423DAA7F

Q34408930-D2DA7DE3-EE33-49FA-8745-D5C2512303A8

Q34408930-D750398F-F933-4577-9E49-FD971EB75B5B

Q34408930-D954586C-93A0-439A-8DA5-4FDE4648CF80

P2860

Q34408930-0BFB98C3-8197-4861-9191-2B756AED0CDD

Q34408930-10A13A07-99E3-4CC9-B2CB-2E801163F303

Q34408930-1DECD142-67E9-4D86-B914-9429791108CA

Q34408930-1FA917AA-D2CE-4AC8-B5D1-48751BE9E9A7

Q34408930-22A7ED30-B62B-4F5B-9C4C-E1ED7479209C

Q34408930-2CEA6E6D-BB2D-4F1E-AF49-747654D58278

Q34408930-31630535-2F37-42B4-B155-9E81670E80EA

Q34408930-31AD0673-B915-407A-9005-872038B32921

Q34408930-37B836B4-0462-442E-93A6-C3D603E17F87

Q34408930-3DA0E7F3-0AA5-4873-A87F-23D8D7D6C2FE

P304

Q34408930-7FDE56A9-04BA-41CC-97B3-62D68E292930

P31

Q34408930-FF2342E8-CBA8-4C3C-8C95-BBB662354422

P356

Q34408930-0A254892-C0B3-4B94-8C7E-4E62FB09D729

P407

Q34408930-C4608F4B-F1B1-4B58-BEFE-CD97B834C6A9

P433

Q34408930-F07F8DD9-20CC-41AB-97AB-89D0C044475D

P478

Q34408930-3CFC2525-105F-4B5A-BECD-13AB92DB4D60

P50

Q34408930-13099D6F-07D3-4CC9-850C-6B235D407570

Q34408930-36D75068-258B-41FA-8467-41CEED39E225

P577

Q34408930-10BD804D-4D19-4112-A3DF-D061EF827532

P5875

Q34408930-CCE5F782-609F-4A9F-816F-FBC85ED530BF

P698

Q34408930-4966B322-8524-43B8-84B1-54B49C8067E6

P921

Q34408930-1D7B19ED-6904-4901-8CE9-F356BE62E1CA

Q34408930-998CEF64-AEE4-4270-A3C8-923FC9C10DA9

P932

Q34408930-17B4F528-2984-4E4A-A393-982B742C68D7

P356

J.AJPATH.2014.01.009

P1433

The American Journal of Pathology

P1476

Ceramide-activated phosphatase ...... ance and impaired angiogenesis

@en

P2093

Albert J Sinusas

http://www.w3.org/2001/XMLSchema#string

Elias Jackson

http://www.w3.org/2001/XMLSchema#string

Jeffrey R Bender

http://www.w3.org/2001/XMLSchema#string

Jun Yu

http://www.w3.org/2001/XMLSchema#string

Pascal Bernatchez

http://www.w3.org/2001/XMLSchema#string

Timur O Yarovinsky

http://www.w3.org/2001/XMLSchema#string

Vishal C Mehra

http://www.w3.org/2001/XMLSchema#string

William C Sessa

http://www.w3.org/2001/XMLSchema#string

Xian M Zhang

http://www.w3.org/2001/XMLSchema#string

Xian-Cheng Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance

Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin

Serine palmitoyl-CoA transferase (SPT) deficiency and sphingolipid levels in mice

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

Vascular growth factor expression in a rat model of severe limb ischemia.

In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.

Therapeutic angiogenesis for coronary artery disease.

Vascular function, insulin resistance and fatty acids.

Dietary fat, fatty acid composition in plasma and the metabolic syndrome.

P304

1562-1576

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AJPATH.2014.01.009

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

184

http://www.w3.org/2001/XMLSchema#string

P50

Wawrzyniec L Dobrucki

Gerald I. Shulman

P577

2014-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260644453

http://www.w3.org/2001/XMLSchema#string

P698

24606881

http://www.w3.org/2001/XMLSchema#string

P921

P932

4005977

http://www.w3.org/2001/XMLSchema#string